Comparison | OR (95% CI) | P value |
Intervention (Kalomo) versus comparator (Monze) at baseline | 0.56 (0.37 to 0.85) | 0.006 |
Intervention (Kalomo) versus comparator (Monze) at endline | 3.67 (1.77 to 7.61) | 0.000 |
Intervention (Kalomo) endline versus baseline | 4.71 (2.68 to 8.26) | 0.000 |
Comparator (Monze) endline versus baseline | 0.72 (0.43 to 1.19) | 0.200 |
Time by study-arm interaction | 6.55 (2.96 to 14.49) | 0.000 |
Intervention (Katete) versus comparator (Petauke) at baseline | 1.06 (0.74 to 1.52) | 0.749 |
Intervention (Katete) versus comparator (Petauke) at endline | 1.57 (0.78 to 3.15) | 0.208 |
Intervention (Katete) endline versus baseline | 1.07 (0.65 to 1.78) | 0.787 |
Comparator (Petauke) endline versus baseline | 0.73 (0.46 to 1.15) | 0.173 |
Time by study-arm interaction | 1.48 (0.69 to 3.17) | 0.317 |
Adjusted for within-site correlation using the robust variance estimate.
Figures in bold font denote statistically significant values.
ORS, oral rehydration salts.